<DOC>
	<DOCNO>NCT00379730</DOCNO>
	<brief_summary>Prednisolone use model medication identify new clinical outcome future evaluation new therapy short-term study ( 4 week ) patient Chronic Obstructive Pulmonary Disease ( COPD ) .</brief_summary>
	<brief_title>Prednisolone Novel Endpoint Study Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>An established clinical history COPD Evidence bronchitis Current exsmoker COPD exacerbation require steroid and/or antibiotic last month Taking oral inhaled steroid 14 day last 6 month Unable withhold salbutamol/albuterol 6 hour period History alcohol , substance drug abuse within last year . Other significant medical condition e.g . diabetes Cancer complete remission least 5 year As result medical interview , physical examination screen investigation , doctor considers subject unfit study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>CT scan</keyword>
	<keyword>breathing test</keyword>
	<keyword>lung function test</keyword>
	<keyword>biomarkers</keyword>
	<keyword>prednisolone</keyword>
	<keyword>IOS</keyword>
	<keyword>COPD</keyword>
	<keyword>clinical outcome</keyword>
</DOC>